Reference Laboratory of Qazvin Medical University, Iran Sana Medical Genetics Laboratory, Qazvin, Iran
Shahid Beheshti University of Medical Sciences, Department of General Surgery, Tehran, Iran
J Clin Res Pediatr Endocrinol. 2023 Aug 23;15(3):318-323. doi: 10.4274/jcrpe.galenos.2021.2021.0186. Epub 2021 Dec 30.
Osteoporosis-pseudoglioma syndrome (OPPG) is a rare autosomal recessive disorder characterized by severe osteoporosis and eye abnormalities that lead to vision loss. In this study, clinical findings and genetic study of two siblings with OPPG are presented. Whole exome sequencing of DNA enriched for exonic regions was performed with SureSelect 38Mbp all exon kit v. 7.0. The two siblings presented with different clinical manifestations of OPPG. The younger female sibling had blindness and severe osteoporosis with multiple fractures, while her older brother was also blind but with less severe osteoporosis and no fractures. On analysis, a novel homozygous nonsense mutation (c.351G>A) in exon 2 of (NM_002335) was found, predicted to change a tryptophan at 117 to a stop codon (p. Trp117Ter). Thus, a variable phenotype was associated with an identical variant in these two siblings. The novel mutation reported herein expands the spectrum of the underlying genetic pathology of OPPG.
骨质疏松性假瘤综合征(OPPG)是一种罕见的常染色体隐性遗传病,其特征为严重的骨质疏松症和导致视力丧失的眼部异常。本研究报告了两例 OPPG 患者的临床发现和基因研究。使用 SureSelect 38Mbp 全外显子试剂盒 v.7.0 对 DNA 进行外显子区域富集的全外显子组测序。这对同胞兄妹表现出不同的 OPPG 临床表现。妹妹为失明和严重的骨质疏松症,伴有多处骨折,而哥哥也失明,但骨质疏松症较轻,没有骨折。分析发现,(NM_002335)外显子 2 中的一个新型纯合无义突变(c.351G>A),预测将色氨酸 117 突变为终止密码子(p.Trp117Ter)。因此,这两个同胞兄妹的相同变异与可变表型相关。本报告中的新突变扩展了 OPPG 潜在遗传病理的范围。